oculotect fluid 50mg/ml
s.a. alcon - povidonum iodinatum - pic. oft.,sol. - 50mg/ml - alte medicamente folosite in oftalmologie alte medicamente folosite in oftalmologie
oculotect fluid 50mg/ml
s.a. alcon - povidonum iodinatum - pic. oft.,sol. - 50mg/ml - alte medicamente folosite in oftalmologie alte medicamente folosite in oftalmologie
regulax 0,71 g + 0,3 g comprimate masticabile
krewel meuselbach gmbh - frunze sennae, fructe sennae angustifolia - comprimate masticabile - 0,71 g + 0,3 g
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
travocort 10 mg/1 mg/1 g
bayer healthcare manufacturing s.r.l. - italia - combinatii - crema - 10mg/1mg/1g - corticosteroizi alte combinatii corticosteroizi cu potenta mare in alte combinatii
advantan 1 mg/g unguent
bayer healthcare manufacturing s.r.l. - italia - alprazolamum aceponat - unguent - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)
advantan 1mg/g crema
bayer healthcare manufacturing s.r.l. - italia - alprazolamum aceponat - crema - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)
advantan milk 1mg/g
bayer healthcare manufacturing s.r.l. - italia - alprazolamum aceponat - emulsie cut. - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)
rotateq vaccin rotavirus viu pentavalent 1 doză soluţie orală
merck sharp & dohme idea gmbh - vaccin rotavirus, viu, pentavalentă - soluţie orală - 1 doză
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologice - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.